Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease

This report shows poor adherence to the recommended treatment regimen for NTM-PD patients, which may pose a potential risk for the development of macrolide resistance. The risk was highest among elderly patients, and those with rheumatoid arthritis and COPD. http://bit.ly/3aBoUzE

Detalles Bibliográficos
Autores principales: Izumi, Kiyohiko, Morimoto, Kozo, Uchimura, Kazuhiro, Ato, Manabu, Hasegawa, Naoki, Mitarai, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Original Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086070/
https://www.ncbi.nlm.nih.gov/pubmed/32211437
http://dx.doi.org/10.1183/23120541.00097-2019
_version_ 1783509056002981888
author Izumi, Kiyohiko
Morimoto, Kozo
Uchimura, Kazuhiro
Ato, Manabu
Hasegawa, Naoki
Mitarai, Satoshi
author_facet Izumi, Kiyohiko
Morimoto, Kozo
Uchimura, Kazuhiro
Ato, Manabu
Hasegawa, Naoki
Mitarai, Satoshi
author_sort Izumi, Kiyohiko
collection PubMed
description This report shows poor adherence to the recommended treatment regimen for NTM-PD patients, which may pose a potential risk for the development of macrolide resistance. The risk was highest among elderly patients, and those with rheumatoid arthritis and COPD. http://bit.ly/3aBoUzE
format Online
Article
Text
id pubmed-7086070
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-70860702020-03-24 Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease Izumi, Kiyohiko Morimoto, Kozo Uchimura, Kazuhiro Ato, Manabu Hasegawa, Naoki Mitarai, Satoshi ERJ Open Res Original Research Letters This report shows poor adherence to the recommended treatment regimen for NTM-PD patients, which may pose a potential risk for the development of macrolide resistance. The risk was highest among elderly patients, and those with rheumatoid arthritis and COPD. http://bit.ly/3aBoUzE European Respiratory Society 2020-03-23 /pmc/articles/PMC7086070/ /pubmed/32211437 http://dx.doi.org/10.1183/23120541.00097-2019 Text en Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Original Research Letters
Izumi, Kiyohiko
Morimoto, Kozo
Uchimura, Kazuhiro
Ato, Manabu
Hasegawa, Naoki
Mitarai, Satoshi
Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease
title Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease
title_full Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease
title_fullStr Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease
title_full_unstemmed Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease
title_short Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease
title_sort population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease
topic Original Research Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086070/
https://www.ncbi.nlm.nih.gov/pubmed/32211437
http://dx.doi.org/10.1183/23120541.00097-2019
work_keys_str_mv AT izumikiyohiko populationbasedsurveyofantimycobacterialdruguseamongpatientswithnontuberculosismycobacterialpulmonarydisease
AT morimotokozo populationbasedsurveyofantimycobacterialdruguseamongpatientswithnontuberculosismycobacterialpulmonarydisease
AT uchimurakazuhiro populationbasedsurveyofantimycobacterialdruguseamongpatientswithnontuberculosismycobacterialpulmonarydisease
AT atomanabu populationbasedsurveyofantimycobacterialdruguseamongpatientswithnontuberculosismycobacterialpulmonarydisease
AT hasegawanaoki populationbasedsurveyofantimycobacterialdruguseamongpatientswithnontuberculosismycobacterialpulmonarydisease
AT mitaraisatoshi populationbasedsurveyofantimycobacterialdruguseamongpatientswithnontuberculosismycobacterialpulmonarydisease

Ejemplares similares